Market Research Future has added a report titled “RSV Diagnostics Market Research Report
– Forecast to 2023” to its offering.
Market Highlights:
Respiratory Syncytial Virus (RSV) is a virus that can cause serious respiratory infections
such as pneumonia and bronchitis. The increasing incidence rate of respiratory infections,
growing demand for in-vitro diagnostics, and growing neonatal population are major factors
propelling the growth of the market. For instance, according to the Centres for Disease
Control and Prevention, in the United States, RSV on an average lead to 57,527
hospitalizations among children below five years of age. On the other hand, some factor
such as lack of availability of specific treatment options for RSV infections and the high
number of other pathogens that cause similar symptoms of respiratory illness may hamper
the growth of the market during the assessment period.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6217
Global RSV Diagnostics Key Players:
Some of the key players in the global RSV diagnostics market are Quest Diagnostics,
Biomerieux, Becton, Dickinson, and Company (BD), Abbott, F. Hoffman-La Roche Ltd.,
Danaher Corporation, Thermo Fisher Scientific, Biocartis, Luminex, Hologic, Fast Track
Diagnostics, Bio-Rad Laboratories Inc., Alere, Inc., Quidel Corporation, and others.
Segmentation:
The global RSV diagnostics market is segmented on the basis of the product, method, and
end-user. On the basis of the product, the market is classified into kits and assays,
instruments, and other products. The global RSV diagnostics market on the basis of the
method is segmented into molecular diagnostics, rapid antigen detection test, gel
microdroplets, flow cytometry, and others. The rapid antigen detection tests are further
classified into enzyme-linked immunosorbent assays, immunofluorescence assays, and
other rapid antigen detection tests. Further, the other rapid antigen detection tests are
classified into chromatographic immunoassays and optical immunoassays. Furthermore, on
the basis of end-user, the market is segmented into hospitals and clinics, clinical
laboratories, home care, and others.
Regional Analysis:
The Americas is likely to dominate the global RSV diagnostics market during the forecast
period. The market growth is attributed to increasing incidences of RSV infections,
increasing government funding's, and increasing infant population. Additionally, growing
demand for molecular diagnostics and chromatographic immunoassays in this region owing
to the high accuracy, sensitivity, and specificity these devices provide. For instance, as per
the data stated by the Centres for Disease Control and Prevention, in the United States,
RSV leads to an estimated 2.1 million outpatient visits among children below five years of
age every year. Europe is anticipated to be the second largest market in the global RSV
diagnostics market. The European market is expected to grow during the forecast period
owing to the growing occurrence of RSV infections and growing government funding for
respiratory diseases. Asia Pacific is expected to be the fastest growing market owing to the
high population base, increasing prevalence of respiratory diseases such as pneumonia and
bronchitis, and growing demand for automated healthcare testing for the accurate diagnosis
of diseases. Furthermore, the Middle East and Africa are expected to show the least growth
in the global RSV diagnostics market. The market growth in these regions is attributed to
the constantly improving healthcare infrastructure, economic development, and rising
patient awareness levels.
Browse Full Reports @ https://www.marketresearchfuture.com/reports/rsv-diagnostics-
market-6217
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology